APA (7th ed.) Citation

CB, G., JJV, M., S, Y., P, H., EL, M., B, O., . . . Committees, C. I. a. (2003). Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: The CHARM-Alternative trial. Lancet, 362(9386), 772. https://doi.org/10.1016/s0140-6736(03)14284-5

Chicago Style (17th ed.) Citation

CB, Granger, et al. "Effects of Candesartan in Patients with Chronic Heart Failure and Reduced Left-ventricular Systolic Function Intolerant to Angiotensin-converting-enzyme Inhibitors: The CHARM-Alternative Trial." Lancet 362, no. 9386 (2003): 772. https://doi.org/10.1016/s0140-6736(03)14284-5.

MLA (9th ed.) Citation

CB, Granger, et al. "Effects of Candesartan in Patients with Chronic Heart Failure and Reduced Left-ventricular Systolic Function Intolerant to Angiotensin-converting-enzyme Inhibitors: The CHARM-Alternative Trial." Lancet, vol. 362, no. 9386, 2003, p. 772, https://doi.org/10.1016/s0140-6736(03)14284-5.